Title:
The use for dealing with a 1 and 4* 2 substitution Pyridazine derivative and the state relevant to a SMN deficit
Document Type and Number:
Japanese Patent JP2016527272
Kind Code:
A
Abstract:
本発明は、式ＩＡの化合物または薬学的に許容されるその塩；５（ＩＡ）本発明の化合物を製造するための方法、およびその治療用途を提供する。本発明はさらに、薬理学的に活性な物質の組み合わせ物および医薬組成物を提供する。【化１】【選択図】 なし
Inventors:
Chun, Atwood
Dales, Natalie
Harley, Timothy Brian
Dales, Natalie
Harley, Timothy Brian
Application Number:
JP2016531875A
Publication Date:
September 08, 2016
Filing Date:
July 30, 2014
Export Citation:
Assignee:
Novartis Age
International Classes:
C07D401/04; A61K31/496; A61K31/501; A61K31/517; A61K31/5377; A61K45/00; A61P21/02; A61P43/00; C07D401/14; C07D407/14; C07D413/14; C07D487/04
Domestic Patent References:
| JP2009537562A | 2009-10-29 |
Foreign References:
| WO2011009890A2 | 2011-01-27 | |||
| US20080064703A1 | 2008-03-13 | |||
| WO2008116816A1 | 2008-10-02 | |||
| WO2008005368A2 | 2008-01-10 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki
Previous Patent: A constituent and a method for inducing urination and defecation
Next Patent: The Afcoscos -ized anti-FGFR2IIIB antibody
Next Patent: The Afcoscos -ized anti-FGFR2IIIB antibody